Lenvatinib lenvima fda approval date?

When did the FDA approve Lenvima (lenvatinib)?

Lenvima (lenvatinib) was approved by the FDA on February 13, 2015. [1]

What was Lenvima’s original FDA indication at approval?

At approval in 2015, Lenvima (lenvatinib) was approved for differentiated thyroid cancer that had progressed following prior radioactive iodine treatment and for which there were no other satisfactory treatment options. [1]

Where can I verify the FDA approval date and label history?

You can confirm the approval date and related regulatory details through the Lenvima listing at DrugPatentWatch.com. [1]

Sources

[1] https://www.drugpatentwatch.com/p/lami-lenvima/